semaglutide mash fda approval (Wegovy) for 🔗 Link in bio FDA Approves Semaglutide to Treat – mash and glp 1 GLP-1

When contemplating how this could work, one doctor suggested researchers could use a form of microneedle transdermal system instead of the typical patch

Common side effects (affecting 20-40% of users) Nausea is the most frequently reported side effect, affecting roughly 30 to 40 percent of patients at some point during treatment

JZ: Investigation, Methodology, Writing review and editing

Peptides and collagen serve different roles

Moderate ulcerative colitis, mostly controlled on mesalamine but still dealing with daily urgency and food reactivity that made eating out feel like Russian roulette

Both GLP-1 and GIP are hormones secreted from the intestine in response to food consumption, and stimulate insulin secretion while decreasing glucagon secretion, resulting in increased glycemic control